Search Results

You are looking at 1 - 10 of 46 items for :

  • "polycystic ovarian syndrome" x
  • Refine by Access: All content x
Clear All
Open access

Liza Haqq, James McFarlane, Gudrun Dieberg, and Neil Smart

Introduction Polycystic ovarian syndrome (PCOS) is a heterogeneous endocrine disorder, affecting 18–22% of reproductive-age women (1) . PCOS was first reported in 1935 by Stein & Leventhal (2) and is characterised by clinical or biochemical

Open access

Ladan Younesi, Zeinab Safarpour Lima, Azadeh Akbari Sene, Zahra Hosseini Jebelli, and Ghazaleh Amjad

Introduction Polycystic ovarian syndrome (PCOS) is one of the most common endocrinopathies in humans, which affects five to ten percent of women in childbearing age ( 1 ). About 20 to 30 percent of women in reproductive age show polycystic

Open access

Gunjan Garg, Garima Kachhawa, Rekha Ramot, Rajesh Khadgawat, Nikhil Tandon, V Sreenivas, Alka Kriplani, and N Gupta

(OH)D level further inhibit the application of vitamin D intervention trials. Polycystic ovarian syndrome (PCOS) is now recognized as one of the most common endocrinopathies in women of reproductive age with a prevalence of 4–10% (9) . Women with PCOS

Open access

Line K Johnson, Kirsten B Holven, Njord Nordstrand, Jan R Mellembakken, Tom Tanbo, and Jøran Hjelmesæth

Introduction Women with polycystic ovarian syndrome (PCOS) are often overweight and have a central fat distribution (1) . It is well known that abdominal obesity is associated with insulin resistance, metabolic syndrome (MS) and increased risk of

Open access

Thomas Reinehr, Alexandra Kulle, Juliane Rothermel, Caroline Knop-Schmenn, Nina Lass, Christina Bosse, and Paul-Martin Holterhus

Introduction Polycystic ovarian syndrome (PCOS) is a heterogeneous syndrome that is characterized by features of anovulation (amenorrhea and oligomenorrhea) combined with symptoms of androgen excess (hirsutism, acne and alopecia) ( 1 ). The

Open access

Rosalie Cabry, Philippe Merviel, Aicha Madkour, Elodie Lefranc, Florence Scheffler, Rachel Desailloud, Véronique Bach, and Moncef Benkhalifa

use (especially in an occupational setting) on female reproductive capacity and certain female infertility diseases, such as premature ovarian failure (POF), polycystic ovarian syndrome (PCOS), and endometriosis. Furthermore, pesticide exposure might

Open access

Mojca Jensterle, Nika Aleksandra Kravos, Simona Ferjan, Katja Goricar, Vita Dolzan, and Andrej Janez

Introduction Polycystic ovarian syndrome (PCOS) brings significant heterogeneity of cardio-metabolic risk at the time of the confirmed diagnosis ( 1 ). Obesity, menstrual irregularity and hyperandrogenism are recognized as the most important

Open access

Nafiye Helvaci, Erdem Karabulut, Ahmet Ugur Demir, and Bulent Okan Yildiz

of following terms: obstructive sleep apnea or OSA or sleep disordered breathing or SDB or sleep and polycystic ovary syndrome or polycystic ovarian syndrome or PCOS. The reference lists of relevant publications were also checked for additional

Open access

Mírian Romitti, Vitor C Fabris, Patricia K Ziegelmann, Ana Luiza Maia, and Poli Mara Spritzer

inflammation in polycystic ovarian syndrome . Gynecological Endocrinology 2012 28 974 – 978 . ( ) 10.3109/09513590.2012.683082 18 van Gelderen CJ Gomes dos Santos ML . Polycystic ovarian syndrome. Evidence

Open access

Neil R Chappell, Beth Zhou, Amy K Schutt, William E Gibbons, and Chellakkan S Blesson

Women’s Health 2015 7 745 – 763 . ( ) 3 Liu L Tong X Jiang L Li TC Zhou F Zhang S . A comparison of the miscarriage rate between women with and without polycystic ovarian syndrome undergoing IVF